A detailed history of Voya Investment Management LLC transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, Voya Investment Management LLC holds 65,897 shares of BLUE stock, worth $23,063. This represents 0.0% of its overall portfolio holdings.

Number of Shares
65,897
Previous 65,897 -0.0%
Holding current value
$23,063
Previous $64,000 46.88%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$0.85 - $1.26 $4,807 - $7,126
5,656 Added 9.39%
65,897 $64,000
Q1 2024

May 15, 2024

BUY
$0.91 - $1.75 $15,535 - $29,876
17,072 Added 39.55%
60,241 $77,000
Q4 2023

Feb 14, 2024

SELL
$1.32 - $4.83 $498 - $1,825
-378 Reduced 0.87%
43,169 $59,000
Q2 2023

Aug 14, 2023

BUY
$2.79 - $5.03 $12,834 - $23,138
4,600 Added 11.81%
43,547 $143,000
Q1 2023

May 15, 2023

BUY
$3.14 - $8.22 $20,375 - $53,339
6,489 Added 19.99%
38,947 $123,000
Q4 2022

Feb 14, 2023

BUY
$5.77 - $8.49 $10,697 - $15,740
1,854 Added 6.06%
32,458 $224,000
Q3 2022

Mar 03, 2023

SELL
$3.75 - $7.39 $6,952 - $13,701
-1,854 Reduced 5.71%
30,604 $193,000
Q3 2022

Nov 14, 2022

SELL
$3.75 - $7.39 $105,401 - $207,710
-28,107 Reduced 47.87%
30,604 $194,000
Q2 2022

Aug 15, 2022

BUY
$2.94 - $5.23 $5,974 - $10,627
2,032 Added 3.59%
58,711 $243,000
Q1 2022

May 16, 2022

BUY
$4.07 - $10.6 $40,191 - $104,675
9,875 Added 21.1%
56,679 $275,000
Q4 2021

Feb 14, 2022

BUY
$8.96 - $16.31 $178,572 - $325,058
19,930 Added 74.16%
46,804 $468,000
Q3 2021

Nov 15, 2021

BUY
$11.24 - $21.0 $2,899 - $5,418
258 Added 0.97%
26,874 $514,000
Q2 2021

Aug 16, 2021

BUY
$18.04 - $22.09 $208,668 - $255,515
11,567 Added 76.86%
26,616 $851,000
Q1 2021

May 17, 2021

SELL
$16.59 - $33.89 $13,205 - $26,976
-796 Reduced 5.02%
15,049 $454,000
Q4 2020

Feb 16, 2021

SELL
$27.5 - $37.92 $18,590 - $25,633
-676 Reduced 4.09%
15,845 $686,000
Q3 2020

Nov 16, 2020

SELL
$34.44 - $43.75 $16,186 - $20,562
-470 Reduced 2.77%
16,521 $891,000
Q2 2020

Aug 14, 2020

BUY
$27.12 - $45.97 $193,880 - $328,639
7,149 Added 72.64%
16,991 $1.04 Million
Q1 2020

May 15, 2020

BUY
$26.16 - $63.5 $4,028 - $9,779
154 Added 1.59%
9,842 $452,000
Q4 2019

Feb 14, 2020

SELL
$46.96 - $61.67 $3,803 - $4,995
-81 Reduced 0.83%
9,688 $850,000
Q3 2019

Nov 14, 2019

SELL
$59.47 - $93.1 $523,276 - $819,186
-8,799 Reduced 47.39%
9,769 $897,000
Q2 2019

Aug 14, 2019

SELL
$75.84 - $105.21 $581,768 - $807,065
-7,671 Reduced 29.24%
18,568 $2.36 Million
Q1 2019

May 15, 2019

SELL
$64.44 - $104.11 $176,307 - $284,844
-2,736 Reduced 9.44%
26,239 $4.13 Million
Q4 2018

Feb 14, 2019

BUY
$59.1 - $93.26 $34,928 - $55,116
591 Added 2.08%
28,975 $2.87 Million
Q3 2018

Nov 14, 2018

BUY
$88.86 - $117.49 $251,829 - $332,966
2,834 Added 11.09%
28,384 $4.15 Million
Q2 2018

Aug 14, 2018

SELL
$99.64 - $127.59 $16.9 Million - $21.7 Million
-169,797 Reduced 86.92%
25,550 $4.01 Million
Q1 2018

May 15, 2018

SELL
$105.8 - $150.94 $1.07 Million - $1.53 Million
-10,116 Reduced 4.92%
195,347 $33.4 Million
Q4 2017

Feb 14, 2018

SELL
$81.25 - $130.7 $10.4 Million - $16.8 Million
-128,258 Reduced 38.43%
205,463 $36.6 Million
Q3 2017

Nov 14, 2017

BUY
$57.74 - $91.42 $19.3 Million - $30.5 Million
333,721
333,721 $45.8 Million

Others Institutions Holding BLUE

About bluebird bio, Inc.


  • Ticker BLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,121,800
  • Market Cap $27M
  • Description
  • bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...
More about BLUE
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.